Introduction {#S1}
============

Chromatin state, which encompasses post-translational modification of histone proteins, integrates environmental signals to influence gene expression and downstream cellular processes. Enzymes that deposit or remove histone modifications regulate lifespan in several species^[@R1],[@R2]^. For example, methyltransferase/demethylase complexes that modify H3K4me3, H3K27me3, and H3K36me3 modulate lifespan in yeast, worms, and flies^[@R1],[@R2]^. Several chromatin-modifying enzymes require intracellular metabolites as co-factors (e.g. NAD+, α-ketoglutarate, or S-adenosyl methionine), rendering their activity exquisitely sensitive to metabolic states^[@R1],[@R2]^. A subset of these chromatin-modifying enzymes, such as deacetylases, in turn influence metabolism^[@R1],[@R2]^. However, the impact of methyltransferases and demethylases on metabolism remains unexplored.

Fat metabolism plays an important role in many physiological and pathological processes. It influences long-term energy storage, inter- and intra-cellular signaling, and membrane homeostasis. In humans, excessive fat storage in the form of triglycerides is associated with diseases such as atherosclerosis and type 2 diabetes^[@R3]^. On the other hand, emerging studies in both invertebrates and mammals suggest that specific alterations in fat profiles, and even elevated fat storage, can be associated with longevity^[@R4]^. Whether fat metabolism links chromatin modifiers to lifespan extension is unknown.

H3K4me3 modifiers impact fat metabolism {#S2}
=======================================

The COMPASS chromatin complex, which catalyzes trimethylation of lysine 4 on histone H3 (H3K4me3)^[@R5]^, regulates lifespan in *C. elegans*^[@R6]^. The H3K4me3 global landscape is remodeled during aging and in cellular senescence in mammals^[@R1],[@R2]^. However, the mechanism by which H3K4me3 modifiers impact longevity remains unclear. To determine whether the COMPASS H3K4me3 methyltransferase complex influences fat metabolism, we used Oil-Red-O (ORO) staining. In fixed tissues, ORO stains neutral lipids such as triglycerides (TAGs)^[@R7]^. Interestingly, worms with deficiency in the COMPASS H3K4me3 methyltransferase SET-2/SET1, which are long-lived^[@R6]^ ([Supplementary Table 1](#SD2){ref-type="supplementary-material"}), exhibit increased ORO staining ([Fig. 1a](#F1){ref-type="fig"}). Conversely, worms deficient for the H3K4me3 demethylase RBR-2/JARID1, which are slightly short-lived^[@R6]^ ([Supplementary Table 1](#SD2){ref-type="supplementary-material"}), display decreased ORO staining ([Fig. 1a](#F1){ref-type="fig"}). RNAi knockdown of *ash-2/ASH2L* and *wdr-5.1/WDR5*, shared components between the COMPASS and Trithorax-related H3K4me3 complexes^[@R5]^, and of *set-2*, a specific component of the COMPASS H3K4me3 complex^[@R5]^, also extended lifespan^[@R6]^ ([Supplementary Table 1](#SD2){ref-type="supplementary-material"}) and increased ORO staining ([Fig. 1b](#F1){ref-type="fig"}, [Extended Data Fig. 1a](#F6){ref-type="fig"}). In contrast, knockdown of *set-16/MLL* and *utx-1/UTX*, specific components of the Trithorax-related H3K4me3 complex^[@R5]^, did not significantly affect ORO levels ([Fig. 1b](#F1){ref-type="fig"}). Thus, the COMPASS H3K4me3 methyltransferase complex specifically influences fat levels.

Fat accumulated most prominently in the intestine in *ash-2* knockdown animals ([Fig. 1c](#F1){ref-type="fig"}), and this was observed at the initiation of reproduction, during reproduction, and post-reproduction ([Fig. 1c](#F1){ref-type="fig"}, [Extended Data Fig. 1b, c](#F6){ref-type="fig"}). The intestinal fat accumulation in *ash-2* knockdown worms was also observed using Nile Red, which stains neutral lipids in fixed tissues^[@R8]^ ([Extended Data Fig. 1d-f](#F6){ref-type="fig"}). Furthermore, gas chromatography coupled to mass spectrometry (GC-MS) showed that *ash-2* knockdown worms have significantly higher levels of TAGs, but similar levels of phospholipids (PLs), compared to controls ([Fig. 1d](#F1){ref-type="fig"}). Fat accumulation in *ash-2* knockdown worms is unlikely to be caused by a shift in fat resources resulting from reduced fertility, because *ash-2* knockdown animals have a similar number of progeny as wild-type animals^[@R6]^ ([Extended Data Fig. 1g](#F6){ref-type="fig"}). Thus, H3K4me3-methyltransferase deficient worms, which are long-lived and fertile, accumulate intestinal fat in the form of TAGs.

H3K4me3 modifiers act mostly in the germline to extend lifespan^[@R6]^, yet fat accumulation occurs in the intestine ([Fig. 1c](#F1){ref-type="fig"}). To determine whether H3K4me3 modifiers act in the germline or intestine to regulate fat accumulation, we performed tissue-selective RNAi knockdown and transgenic rescue experiments. Knockdown of *ash-2* in the intestine (*rde-1(ne219)*; *Is\[Pnhx-2::rde-1\]*^[@R9]^) did not promote fat accumulation or lifespan extension ([Fig. 1e, f](#F1){ref-type="fig"}, [Extended Data Fig. 1h, i](#F6){ref-type="fig"}). Likewise, *set-2* knockdown in the intestine did not increase fat accumulation ([Extended Data Fig. 1j](#F6){ref-type="fig"}), and overexpression of *set-2* in the intestine of *set-2(ok952)* mutants did not abrogate the elevated fat levels of *set-2(ok952)* mutants ([Extended Data Fig. 1k-m](#F6){ref-type="fig"}). These results suggest that H3K4me3 modifiers act mostly outside of the intestine to influence fat accumulation. As strains that allow germline-specific RNAi knockdown do not currently exist in *C. elegans*, we used the *rde-1(ne219);Si\[Pmex-5::rde-1\]* strain, which restricts RNAi to germline and intestine^[@R10]^. Interestingly, *ash-2* knockdown in germline and intestine promoted fat accumulation and extended lifespan ([Fig. 1g, h](#F1){ref-type="fig"}, [Extended Data Fig. 1i](#F6){ref-type="fig"}). Likewise, *set-2* knockdown in germline and intestine also increased fat levels ([Extended Data Fig. 1j](#F6){ref-type="fig"}). Similarly, *ash-2* knockdown in *rrf-1(pk1417)* mutants, in which RNAi is restricted to the germline, intestine, and some hypodermal seam cells^[@R11]^, also increased fat levels and extended lifespan ([Extended Data Fig. 1n](#F6){ref-type="fig"}, [Supplementary Table 1](#SD2){ref-type="supplementary-material"}). Thus, the COMPASS H3K4me3 methyltransferase complex acts mostly in the germline to regulate intestinal fat accumulation and lifespan, implying a germline-to-intestine communication.

A switch to MUFA metabolism {#S3}
===========================

Like mammals, worms have different categories of fatty acids: saturated fatty acids (SFAs), mono-unsaturated fatty acids (MUFAs), and poly-unsaturated fatty acids (PUFAs) ([Fig. 2a](#F2){ref-type="fig"}). To identify specific lipid species associated with longevity in H3K4me3-methyltransferase deficient worms, we profiled long-chain fatty acids by GC-MS. Interestingly, at all ages tested, *ash-2* knockdown increased MUFAs, while SFAs and PUFAs remained mostly unchanged ([Fig. 2b](#F2){ref-type="fig"}). The MUFAs palmitoleic acid and cis-vaccenic acid were significantly elevated at all ages, whereas the MUFA oleic acid was raised post-reproduction in *ash-2* knockdown worms and in worms deficient for *set-2*, a specific component of the COMPASS H3K4me3 complex ([Fig. 2b, c](#F2){ref-type="fig"}). In contrast, MUFAs remained largely unaffected in worms deficient for *set-16* and *utx-1*, specific components of the Trithorax-related H3K4me3 complex ([Extended Data Fig. 2a](#F7){ref-type="fig"}). Thus, the COMPASS H3K4me3 methyltransferase complex specifically impacts MUFA metabolism.

To determine whether this switch to MUFA accumulation arises from changes in fat synthesis, storage, or breakdown, we examined the expression of the specific enzymes that control these steps ([Fig. 2a](#F2){ref-type="fig"}). *ash-2* knockdown strongly increased the expression of delta-9 fatty acid desaturase genes *fat-5* and *fat-7* ([Fig. 2d](#F2){ref-type="fig"}). FAT-5, a palmitoyl-CoA desaturase, preferentially converts palmitic acid into the MUFA palmitoleic acid, whereas FAT-7 and FAT-6, two stearoyl-CoA desaturases, convert stearic acid into the MUFA oleic acid^[@R12]^ ([Fig. 2a](#F2){ref-type="fig"}). Expression of *fat-5* and *fat-7* was also upregulated in *set-2* mutant or knockdown worms ([Extended Data Fig. 2b](#F7){ref-type="fig"}). In contrast, the expression of *fat-2*, which catalyzes the first step in converting MUFAs to PUFAs^[@R13]^, and that of other fat metabolism enzymes (e.g. lipases), was not consistently affected by *ash-2* knockdown ([Fig. 2d](#F2){ref-type="fig"}). Expression of *fat-5* and *fat-7* was elevated in the intestine, but not in the germline, of *ash-2* knockdown worms ([Fig. 2e](#F2){ref-type="fig"}), and *ash-2* acts mostly in the germline to promote this intestinal *fat-5* and *fat-7* elevation ([Fig. 2e](#F2){ref-type="fig"}). Transgenic worms expressing green fluorescent protein (GFP) translational reporters for FAT-5 or FAT-7 also showed increased GFP fluorescence in the intestine upon *ash-2* knockdown ([Fig. 2f](#F2){ref-type="fig"}). Thus, germline H3K4me3-methyltransferase deficiency leads to upregulation of delta-9 desaturases in the intestine, suggesting that MUFA accumulation occurs at the level of synthesis.

We next examined the role of delta-9 desaturases in the MUFA accumulation of H3K4me3-methyltransferase deficient worms. Knockdown of *fat-7* in *ash-2* deficient worms specifically decreased oleic acid levels at the initiation of reproduction and reduced all three MUFAs (oleic, palmitoleic, and cis-vaccenic acid) post-reproduction ([Fig. 2g, h](#F2){ref-type="fig"}, [Extended Data Fig. 2c](#F7){ref-type="fig"}). In contrast, *fat-5* knockdown in *ash-2* deficient worms increased palmitoleic and cis-vaccenic acid ([Extended Data Fig. 2d](#F7){ref-type="fig"}), likely due to compensatory upregulation of *fat-7* ([Extended Data Fig. 2e](#F7){ref-type="fig"}). These results suggest that the MUFA switch in H3K4me3-methyltransferase deficient worms is driven by FAT-7 upregulation in the intestine.

Germline targets of H3K4me3 modifiers {#S4}
=====================================

The H3K4me3 methyltransferase complex acts mostly in the germline to trigger intestinal upregulation of delta-9 desaturases. To better understand this germline-to-intestine communication, we identified germline targets of the H3K4me3 methyltransferase complex. We generated an RNA-seq dataset using micro-dissected germlines and intestines from *ash-2* knockdown worms and analyzed this dataset ([Extended Data Fig. 3a, b](#F8){ref-type="fig"}, [Supplementary Table 2](#SD3){ref-type="supplementary-material"}-[5](#SD6){ref-type="supplementary-material"}) as well as other large-scale datasets^[@R6],[@R14],[@R15]^. Because H3K4me3 methyltransferase complexes generally activate gene expression^[@R5]^, we selected targets that were downregulated in H3K4me3-methyltransferase deficient worms ([Extended Data Table 1](#T1){ref-type="table"}). Using RT-qPCR, we validated that *ash-2* knockdown led to the significant downregulation of four candidates in the germline (*rsks-1/S6 kinase, tbh-1, nhr-10*, and *unc-132*), one candidate in both germline and intestine (*F21A3.11*), and two candidates in the intestine (*asm-2* and *dod-23*) ([Fig. 3a](#F3){ref-type="fig"}, [Extended Data Fig. 3c](#F8){ref-type="fig"}).

We next assessed the functional involvement of these candidates in fat metabolism. Knockdown of *rsks-1, tbh-1, F21A3.11*, or *unc-132* all led to increased ORO staining ([Fig. 3b](#F3){ref-type="fig"}, [Extended Data Fig. 3d-g](#F8){ref-type="fig"}). Among these four targets, *rsks-1* was the only one that acted mostly in the germline to regulate fat accumulation ([Extended Data Fig. 3d-g](#F8){ref-type="fig"}). RSKS-1/S6 kinase is a key conserved substrate of mTOR complex 1^[@R16]^. RSKS-1 deficiency extends lifespan in *C. elegans* and mice^[@R17]^ and promotes fat accumulation in *C. elegans*^[@R18]^. We asked whether *rsks-1* could mediate the fat metabolism switch of H3K4me3-methyltransferase deficient worms. *rsks-1* knockdown or mutation led to increased fat accumulation, MUFA levels, and *fat-7* expression ([Fig. 3b-d](#F3){ref-type="fig"}, [Extended Data 3h-j](#F8){ref-type="fig"}). Interestingly, *ash-2* knockdown could not further increase fat accumulation and *fat-7* expression in *rsks-1* deficient worms ([Fig. 3d](#F3){ref-type="fig"}, [Extended Data 3i, j](#F8){ref-type="fig"}). Likewise, knockdown of the RSKS-1 upstream regulator, *let-363/mTOR*, also led to increased fat accumulation, MUFA levels, and *fat-7* expression ([Extended Data Fig. 3k-n](#F8){ref-type="fig"}), and *ash-2* knockdown did not further increase *fat-7* expression ([Extended Data Fig. 3k](#F8){ref-type="fig"}). Deficiency in RSKS-1 or its upstream regulators (*let-363/mTOR* or *daf-15/Raptor)* all resulted in lifespan extension, and the ability of *ash-2* or *set-2* deficiency to extend lifespan was diminished in the context of *rsks-1* deficiency ([Extended Data Fig. 3o, p](#F8){ref-type="fig"}). Collectively, these data suggest that RSKS-1/S6K is a germline target of the H3K4me3 methyltransferase complex that mediates at least part of the intestinal upregulation of delta-9 desaturases leading to MUFA accumulation.

MUFAs mediate longevity by H3K4me3 modifiers {#S5}
============================================

To examine the role of MUFAs in H3K4me3 modifiers-mediated longevity, we first further explored the molecular mechanisms underlying MUFA accumulation upon H3K4me3-methyltransferase deficiency. Delta-9 desaturases are known targets of a highly conserved intestinal transcriptional network, which involves the transcription factor SBP-1/SREBP^[@R19]^ and the Mediator complex subunit MDT-15/MED15^[@R20]^, as well as other transcription factors such as NHR-49^[@R21]^ and NHR-80/HNF4^[@R22]^ ([Fig. 4a](#F4){ref-type="fig"}). Knockdown of *ash-2* and *set-2*, as well as *set-2* mutation, increased nuclear accumulation of SBP-1::GFP in intestinal cells ([Fig. 4b](#F4){ref-type="fig"}, [Extended Data Fig. 4a](#F9){ref-type="fig"}), and this accumulation was reduced in *rsks-1* deficient animals ([Extended Data Fig. 4b-d](#F9){ref-type="fig"}). We next tested if SBP-1 (and MDT-15) is necessary for delta-9 desaturase upregulation and MUFA accumulation in H3K4me3-methyltransferase deficient worms. Knockdown of *sbp-1* or *mdt-15* decreased the basal levels of *fat-5* and *fat-7* mRNA and blunted their upregulation by *ash-2* knockdown ([Fig. 4c](#F4){ref-type="fig"}, [Extended Data Fig. 4e](#F9){ref-type="fig"}). Knockdown of *sbp-1* or *mdt-15* also blocked the elevation of MUFAs (palmitoleic, cis-vaccenic, and oleic acid) in *ash-2* deficient worms post-reproduction ([Fig. 4d](#F4){ref-type="fig"}, [Extended Data Fig. 4f](#F9){ref-type="fig"}). Thus, SBP-1/SREBP and MDT-15/MED15 are critical for delta-9 desaturase upregulation and MUFA accumulation in H3K4me3-methyltransferase deficient worms.

We next used this molecular knowledge to ask whether the MUFA metabolic switch is causative for the lifespan extension of H3K4me3-methyltransferase deficient worms. Interestingly, deficiency in *sbp-1* or *mdt-15* by knockdown or mutation abolished fat accumulation and lifespan extension in *ash-2* knockdown worms ([Fig. 4e, f](#F4){ref-type="fig"}, [Extended Data Fig. 4g, h](#F9){ref-type="fig"}, [Supplementary Table 1](#SD2){ref-type="supplementary-material"}). Likewise, *sbp-1* knockdown abrogated the longevity of *set-2* mutant worms ([Supplementary Table 1](#SD2){ref-type="supplementary-material"}). In contrast, *nhr-49* mutation only partially diminished the ability of *ash-2* deficiency to promote fat accumulation and lifespan extension ([Extended Data Fig. 4i, j](#F9){ref-type="fig"}) and *nhr-80* mutation had no effect ([Extended Data Fig. 4k, l](#F9){ref-type="fig"}). We also tested if the delta-9 desaturases themselves are required for the longevity of H3K4me3-methyltransferase deficient worms. Interestingly, *fat-7* knockdown and *fat-6;fat-7* double mutants, which are strongly deficient for oleic acid synthesis^[@R23]^, blocked the fat accumulation and longevity of *ash-2* deficient worms ([Fig. 4g, h](#F4){ref-type="fig"}, [Extended Data Fig. 5a, b](#F10){ref-type="fig"}). In contrast, *fat-7* and *fat-6* hypomorphic single mutants (or *fat-5;fat-7* and *fat-5;fat-6* double mutants), which are only mildly deficient for MUFA synthesis^[@R22],[@R23]^, did not abolish the longevity of *ash-2* knockdown worms ([Extended Data Fig. 5c-f](#F10){ref-type="fig"}). Thus, a conserved genetic pathway involving SBP-1/SREBP, MDT-15/MED15, and the downstream delta-9 desaturase FAT-7 is critical for the longevity of H3K4me3-methyltransferase deficient worms.

To more specifically assess the role of MUFAs in H3K4me3-methyltransferase deficient worms, we supplemented oleic acid in the diet ([Extended Data Fig. 5g, h](#F10){ref-type="fig"}). Dietary oleic acid restored in large part the high fat phenotype and lifespan extension of *ash-2;fat-7* double knockdown worms ([Fig. 4g, h](#F4){ref-type="fig"}, [Extended Data Fig. 5i, j](#F10){ref-type="fig"}). Similarly, dietary oleic acid restored high fat levels in *ash-2;sbp-1* double knockdown worms ([Extended Data Fig. 5k](#F10){ref-type="fig"}). Furthermore, knock-down of *fat-2*, which normally converts oleic acid into downstream PUFA^[@R13]^, increased fat accumulation and lifespan extension, and *ash-2* deficiency did not further increase fat levels and extend lifespan in *fat-2* knockdown worms ([Extended Data Fig. 5l-o](#F10){ref-type="fig"}). Thus, the MUFA oleic acid plays a key role in the longevity of H3K4me3-methyltransferase deficient worms.

Dietary MUFAs extend lifespan {#S6}
=============================

The role of oleic acid in lifespan regulation in the context of H3K4me3-methyltransferase deficiency led us to systematically examine the importance of MUFAs and their downstream PUFAs in lifespan regulation under physiological conditions ([Fig. 5a](#F5){ref-type="fig"}). Dietary supplementation of individual MUFAs (oleic, palmitoleic, or cis-vaccenic acid) ([Fig. 5b, d](#F5){ref-type="fig"}, [Extended Data Fig. 6a](#F11){ref-type="fig"}) was sufficient to extend lifespan ([Fig. 5c, e, f](#F5){ref-type="fig"}, [Extended Data Fig. 6b](#F11){ref-type="fig"}). In contrast, dietary supplementation of the two PUFAs linoleic or alpha-linolenic acid ([Extended Data Fig. 6c, e](#F11){ref-type="fig"}) did not significantly affect lifespan ([Extended Data Fig. 6d, f](#F11){ref-type="fig"}, [Fig. 5f](#F5){ref-type="fig"}). All MUFAs and PUFAs tested also increased total fat accumulation, except for the PUFA alpha-linolenic acid ([Fig. 5c, e](#F5){ref-type="fig"}, [Extended Data Fig. 6b, d, f](#F11){ref-type="fig"}). Furthermore, overexpressing the oleic acid-synthesizing enzyme FAT-7 in the intestine increased fat accumulation and extended lifespan ([Fig. 5g](#F5){ref-type="fig"}, [Extended Data Fig. 6g-i](#F11){ref-type="fig"}). Oleic acid supplementation did not further extend the long lifespan of FAT-7 overexpressing worms ([Fig. 5g](#F5){ref-type="fig"}, [Extended Data Fig. 6i](#F11){ref-type="fig"}). Collectively, these results suggest that dietary supplementation and endogenous accumulation of MUFAs, but not downstream PUFAs, are beneficial for lifespan.

Discussion {#S7}
==========

Our study shows that histone methylation modifiers influence MUFA metabolism. We propose a model whereby H3K4me3-methyltransferase deficiency causes the downregulation of specific targets (e.g. RSKS-1/S6K) in the germline, which in turn triggers a germline-to-intestine signal leading to SBP-1/SREBP activation, delta-9 desaturase expression, and MUFA accumulation in the intestine ([Extended Data Fig. 6j](#F11){ref-type="fig"}). The nature of this germline-to-intestine signal is unknown, but it could be a diffusible lipid signal ('lipokine'), a signal from the maturing eggs, or altered levels of lipid-binding proteins. Deficiency in the H3K4me3 methyltransferase complex might also affect fat metabolism by impacting the methyl pool available for other enzymatic reactions or by methylating yet-to-be-identified non-histone substrates.

Our work also shows that dietary MUFAs, but not their downstream PUFAs, positively impact lifespan. Previous studies have tested supplementation of individual fatty acids on lifespan^[@R24]-[@R28]^ and identified other PUFAs implicated in lifespan regulation^[@R24],[@R26]^. Dietary oleic acid did not extend wild-type lifespan in previous studies^[@R25],[@R27],[@R28]^, although they used different oleic acid supplementation protocols. MUFAs could contribute to longevity by promoting membrane fluidity, minimizing oxidative stress, enhancing energy storage, or activating signaling pathways. The beneficial effects of MUFAs are exciting because of their dietary availability (e.g. oleic acid in olives) and microbiotic sources (e.g. palmitoleic acid in *E. coli*)^[@R29]^. In humans, diets rich in MUFAs have been associated with decreased risk of cardiovascular disease and diabetes^[@R30]^. The general conservation of lipid metabolism between worms and mammals raises the interesting possibility that the benefits of MUFAs on healthspan and lifespan could be conserved in other species.

Materials and Methods {#S8}
=====================

Worm strains {#S9}
------------

All strains were maintained on standard nematode growth medium (NGM) plates with *E. coli* (OP50-1, streptomycin-resistant). Unless otherwise noted, worms were grown on the RNAi strain HT115 (DE3) for all experiments. The wild-type N2 strain (ABR) was provided by Dr. Man-Wah Tan. The NL2098 *rrf-1(pk1417)* strain, which restricts RNAi to the germline, intestine, and partially the hypodermal seam cells^[@R11],[@R31]^, was provided by Andrew Fire. The germline and intestine RNAi strain AMJ345 *rde-1(ne219); jamSi2\[Pmex-5::rde-1(+)\]* and corresponding wild-type N2 (AMJ) were provided by Dr. Antony Jose^[@R10]^. The intestine specific RNAi strain VP303 *rde-1(ne219)*; *kbIs7\[nhx-2p::rde-1 + rol-6(su1006)\]* was obtained from *Caenorhabditis* Genetics Center (CGC). Other strains obtained from CGC were as listed: RB1025 *set-2(ok952)*, ZR1 *rbr-2(tm1231)*, DA1116 *eat-2(ad1116)*, XA7702 *mdt-15(tm2182)*, STE68 *nhr-49(nr2041)*, BX165 *nhr-80(tm1011)*, BX153 *fat-7(wa36)*, BX106 *fat-6(tm331)*, BX160 *fat-7(wa36);fat-5(tm420)*, BX110 *fat-6(tm331);fat-5(tm420)*, BX156 *fat-6(tm331);fat-7(wa36)*, RB1206 *rsks-1(ok1255)*, and fluorescence translational fusion reporters BX150 *lin-15B&lin-15A(n765); waEx18\[fat-5::GFP + lin15(+)\]*, BX113 *lin-15B&lin-15A(n765); waEx15\[fat-7::GFP + lin-15(+)\]*, and CE548 *sbp-1(ep79)*; *epEx141\[sbp-1::GFP::SBP-1 + rol-6(su1006)\]*. Mutants *set-2(ok952), rbr-2(tm1231), eat-2(ad1116)*, and transgenic strain CE548 were outcrossed to our laboratory N2 (ABR) at least 6 times. During backcrossing, the *sbp-1(ep79)* mutation in CE548 was removed to generate a SBP-1::GFP translational fusion reporter in a wild-type background. See [Supplementary Table 6](#SD7){ref-type="supplementary-material"} for a list of strains. All experiments were performed using hermaphrodites.

RNA interference {#S10}
----------------

RNAi interference was performed as described^[@R6]^. HT115 (DE3) bacteria were transformed with vectors expressing dsRNA targeting the following genes of interest: *ash-2, set-2, wdr-5.1, set-16, utx-1, jmjd-3.1, fat-2, fat-5, fat-7, mdt-15, sbp-1, tbh-1, nhr-10, F21A3.11, dod-23* (Ahringer Library, Dr. Andrew Fire), *let-363/mTOR* (Dr. Xiaomeng Long), *daf-15/Raptor* (Dr. Allen Hsu), *rsks-1, asm-2* and *unc-132* (Vidal Library, Dharmacon). All vectors were confirmed by sequencing. Empty vector bacteria, containing the RNAi plasmid without an RNAi insert, served as a control for all RNAi experiments. RNAi culture was concentrated 30-fold, and stored at 4°C for no more than 2 weeks. For double RNAi treatments, two cultures were mixed in a 1:1 ratio by volume. To obtain a synchronized worm population, egglay was performed on appropriate RNAi plates for 1-4 hours. All RNAi treatments began at hatching, except for ORO and lifespan experiments using *sbp-1, mdt-15, fat-2, let-363/mTOR*, or *daf-15/Raptor* RNAi, which began at initiation of reproduction (day 2.5 of life) to minimize effects on development.

Lifespan assays {#S11}
---------------

Worm lifespan assays were performed at 20°C as described^[@R32]^. Kaplan-Meir lifespan curves were generated using GraphPad Prism, and statistical results were obtained by log-rank analysis using the JMP software. Two-way ANOVA was used to assess lifespan interactions between conditions. Lifespan assays that were blinded or repeated by an independent investigator are indicated in [Supplementary Table 1](#SD2){ref-type="supplementary-material"}. Representative Kaplan-Meir lifespan curves are shown in the figures and all statistics are included in [Supplementary Table 1](#SD2){ref-type="supplementary-material"}.

Oil Red O and Nile Red staining and quantification {#S12}
--------------------------------------------------

Oil Red O (ORO) staining of fixed worms was conducted as described^[@R7]^, except that 2% Paraformaldehyde in PBS was used to fix worm tissues. ORO staining of dissected intestines was performed for one hour. Nile Red staining of fixed worms was performed as described^[@R33]^, except that staining was conducted in 1.5 mL Eppendorf tubes. ORO- or Nile Red-stained worms were mounted onto 2% agar pads, and imaged at 10x magnification using a Zeiss AxioSkop 2 Plus. Images were acquired using an AxioCam MRc camera with AxioVision 4.7 software and saved as TIF files. The same exposure settings were used across all conditions within each experiment. Using FIJI image processing software, raw images were background-subtracted, grayscale-converted, inverted, and thresholded to outline the worm body. The same threshold values were used across all conditions within each experiment. "Analyze Particles" was used to measure mean ORO intensity per worm. To quantify anterior intestinal cells of whole worms or extruded intestines of dissected worms, specific regions in the raw images were selected using the oval brush tools (intestine cells) or the segmented line tool (extruded intestines), saved to the Region of Interest (ROI) manager, processed as described above, and quantified for mean ORO intensity per selected region. Mean intensity values in arbitrary units (a.u.) were graphed using Graphpad Prism, and statistical significance was determined using a two-tailed Mann-Whitney test (2 conditions) or the Kruskal-Wallis test with Dunn\'s correction for multiple comparisons (more than 2 conditions). For figures containing straightened whole worms or intestines, unmodified images were selected and straightened, and representative worms or intestines from each condition were concatenated into montages.

GFP quantification {#S13}
------------------

For FAT-5::GFP and FAT-7::GFP fluorescence reporters, worms at active reproduction (day 3 of life) were anesthetized in M9 (22 mM KH~2~PO~4~, 42 mM Na~2~HPO~4~, 86 mM NaCl, 1mM MgSO~4~, dissolved in water) containing100 μM levamisole and mounted on 2% agar pads. All images were acquired on Zeiss AxioSkop 2 Plus using an AxioCam MRc camera with AxioVision 4.7 software with identical exposure settings for the same experiment. Mean fluorescence intensity in arbitrary units (a.u.) of the whole worm was quantified in FIJI as described above. These experiments were conducted in a blinded manner. For visualization of intestinal nuclear SBP-1::GFP expression, worms at active reproduction (day 3 of life) were mounted on 2% agarose pads and anesthetized with 20 mM tetramisole in M9. Images were acquired using Zeiss Axio Imager.M2 microscope equipped with an ApoTome.2 system and AxioCam MRc camera using identical exposure settings for the same experiment. Images showing the maximum number of defined intestine nuclei were selected in each animal and saved as TIF files. Mean fluorescence intensity in arbitrary units (a.u.) of each nucleus was quantified using the oval brush tool in FIJI as described above.

Worm tissue micro-dissection {#S14}
----------------------------

Synchronized worms grown on appropriate RNAi bacteria were collected at specified stages of life. At least 20 worms from each condition were washed 3 times with M9 buffer and deposited onto a glass slide in drops of M9 (one worm per drop) with a glass Pasteur pipette. Under the dissection light microscope, individual worms were decapitated using 22.5° knives (Surgistar) to extrude their anterior intestines and full germlines (including developing oocytes). For ORO or Nile Red staining, reproductive worms (day 5 of life) with extruded intestines were used for staining. For RT-qPCR or RNA-seq, fully detached intestines and germlines from worms during active reproduction (day 3 of life) or at initiation of reproduction (day 2.5 of life) were harvested. To isolate the full germline containing maturing oocytes, an incision was made before the spermatheca to minimize sperm contamination. Dissected germlines were immediately collected in 500 μL of Trizol LS reagent (Invitrogen) using a glass Pasteur pipet whose tip was pulled under the flame to thin out the opening. To isolate the anterior intestine from the same worms, an incision was made near the anterior 10 pairs of intestinal cells. The anterior intestine samples were collected in Trizol in separate tubes. All samples were stored at −80°C until RNA extraction.

Quantitative RT-PCR {#S15}
-------------------

For experiments using whole worms, at least 100 aged-synchronized worms in biological triplicate for each condition were harvested, washed 3 times with M9, and resuspended in 500 μL of Trizol. For experiments using dissected tissues, 20-40 germlines or intestines in biological triplicate for each condition were harvested. To extract total RNA, worm or tissue pellets in Trizol underwent six freeze-thaw cycles in a dry ice-ethanol bath. RNA was extracted according to the Trizol procedure, and resuspended in RNase- and DNase-free water. RNA from whole worms was quantified using the Qubit 2.0 fluorometer (Invitrogen), and at least 500 ng of total RNA per condition was used for cDNA synthesis. RNA from dissected tissues was quality-assessed and quantified using the Agilent Bioanalyzer (RNA 6000 Pico), and at least 2 ng of total RNA per condition was used for cDNA synthesis.

Total RNA was treated with DNAse I Amp Grade (Invitrogen), then reverse-transcribed using Oligo-dT primers (Invitrogen) and Superscript III reverse transcriptase (Invitrogen), based on the manufacturer\'s instructions. RT-qPCR was performed using diluted cDNA on an ABI7900HT or a Bio-Rad C1000 thermal cycler using iTaq master mix (Bio-Rad) containing a passive reference dye (ROX™). Primers used in RT-qPCR were designed to span exon-exon junctions towards the 3' end of the gene and used at a final concentration of 250 nM each. Primers are listed in [Supplementary Table 7](#SD8){ref-type="supplementary-material"}. Melt curves were examined to ensure primer specificity. Results were analyzed using the standard ΔΔCT method. For each biological replicate, the mean CT value of 3-4 technical replicates was analyzed. *act-1* served as the reference gene in all analyses, and changes in mRNA levels relative to *act-1* were confirmed using either *cdc-42, ama-1*, or *pmp-3* as alternate reference genes in independent experiments (data not shown).

RNA-seq on micro-dissected tissues {#S16}
----------------------------------

For each of the five replicates, full germlines and anterior intestines were collected from 20 worms treated with *ash-2* RNAi or empty vector control. At the initiation of reproduction (day 2.5 of life), worms from each pair of *ash-2* RNAi and empty vector plates were dissected within the same hour. Tissue dissection and RNA extraction procedures were the same as described above and 20 full germlines or \~200 intestinal cells were used as initial input for individual RNA-seq libraries. For cDNA synthesis, 150 pg (intestine) or 750 pg (germline) of extracted RNA was treated with RQ1 RNase-free DNase (Promega), which was later removed, and reverse transcribed using oligo(dT)-primed, Clontech SMART-Seq v4 Ultra Low Input RNA Kit (634889) according to manufacturer\'s instructions. Poly-A selected RNA-seq libraries were generated using Illumina Nextera XT DNA Library Prep Kit (FC-131-1024). All 20 libraries were processed together to minimize batch effects. The libraries were uniquely barcoded and multiplexed onto one lane, and 150 base pair paired-end reads were sequenced on NextSeq 500 (Illumina).

RNA-seq analysis {#S17}
----------------

RNA-seq reads were aligned to the WBcel235 genome and gene read counts were calculated using STAR v2.5.1b^[@R34]^. Low-coverage genes were filtered out: only genes with at least 1 read count per million mapped reads in at least 5 samples were included in the analysis, resulting in a dataset of 10,442 genes and 20 samples. More genes were detected in the germline samples (185 genes with a median count number of 0) than in the intestine samples (682 genes with a median count number of 0), with 76% of the genes having a higher median read count in germline samples than in intestine samples. Because of these tissue-specific differences, we did not perform an across-sample normalization (which assumes that most genes are not differentially expressed) and instead used FPKM values to compare germline and intestine samples. The read counts were transformed to log2(FPKM+1) values, which were used for the principal component analysis (PCA) on the samples from both tissues together. A gene was determined to be germline-enriched if the lowest expression value (log2(FPKM+1)) in the germline empty-vector samples was at least 2-fold higher than the highest expression value in the intestine empty-vector samples (5,494 germline-enriched genes). A gene was determined to be intestine-enriched if the lowest expression value (log2(FPKM+1)) in the intestine empty-vector samples was at least 2-fold higher than the highest expression value in the germline empty-vector samples (1,418 intestine-enriched genes).

We then compared empty-vector and *ash-2* RNAi samples for each tissue separately. Low-coverage genes were filtered out: only genes with at least 1 read count per million mapped reads in at least 5 samples were included in the analysis. This resulted in a germline dataset of 9,073 genes and 10 samples, and an intestine dataset of 7,288 genes and 10 samples. Using DESeq2 v1.10.1^[@R35]^, the read counts were normalized using the variance stabilizing transformation (VST) within each tissue and PCA was performed on the germline and intestine dataset. For each tissue, differentially expressed genes between empty-vector and *ash-2* RNAi were examined, accounting for a plate effect (GE \~ condition + plate). Gene-wise *P* values were corrected for multiple hypothesis testing using Benjamini-Hochberg and FDR = 0.05 was used as a significance threshold.

Selection of ASH-2 candidate targets {#S18}
------------------------------------

ASH-2 candidate targets were selected based on the following datasets: 1) our RNA-seq dataset, 2) microarrays on *ash-2* knockdown larval worms^[@R6]^ and *ash-2* mutant adult germlines^[@R14]^, and 3) ASH-2 ChIP-chip on worm embryos^[@R15]^. Predicted candidate expression in germline/intestine for datasets 2) and 3) was based on published gene expression datasets^[@R36]-[@R38]^ (Andreas Rechtsteiner and Susan Strome, personal communication) and pre-publication RNA-seq datasets (Robert Waterston, personal communication). The following criteria were used to select potential targets: i) downregulation upon *ash-2* deficiency, as the H3K4me3 methyltransferase complex is generally associated with gene activation; ii) expression in the germline or intestine, as these are the two key tissues involved in this fat metabolic switch; and/or iii) previously identified role in lifespan or fat metabolism.

Generation of transgenic plasmids {#S19}
---------------------------------

The *Pges-1::fat-7* plasmid (pSH1) contains 2kb of *ges-1* promoter region (*Pges-1*) upstream of *fat-7* full genomic DNA sequence followed by *fat-7* 3' UTR in the P4-P1R vector. The plasmid containing *Pges-1* in the P4-P1R vector was a gift from Dr. Frederick Mann. The fragment containing *fat-7* full genomic DNA (containing the coding region and 3'UTR) was generated by PCR amplification from wild-type (N2) genomic DNA using the following primers (pSH1\_*fat-7\_*F: 5'-CTATTACATATCTTATCTTTGAATTCAGATGACGGTAAAAACTCGCGCGAGCATTGCCAA-3' and pSH1\_*fat-7\_*R: 5'-GCCGCCCTGCAGCTCTAGAGCTCGAATTCTTAGAATTAACCAAATTTATTCAGGAATAA-3'). The fragment containing *Pges-1* and the P4-P1R vector was PCR-amplified using the following primers (pSH1\_*Pges-1* \_F: 5'-TTGGCAATGCTCGCGCGAGTTTTTACCGTCATCTGAATTCAAAGATAAGATATGTAATAG-3'and pSH1\_*Pges-1\_*R: 5'-TTTATTCCTGAATAAATTTGGTTAATTCTAAGAATTCGAGCTCTAGAGCTGCAGGGCGGC-3'). The fragments were assembled via Gibson assembly^[@R39]^.

The *Pges-1::set-2a cDNA::SL2::GFP* plasmid (pSH9) contains 2kb of *ges-1* promoter region (*Pges-1*) upstream of the full-length cDNA of *set-2.a* (the long isoform of *set-2*) followed by the SL2 trans-splicing sequence, GFP cDNA, and *unc-54* 3'UTR in the pIM26 vector. pIM26 containing SL2 upstream of GFP and *unc-54* 3'UTR was a gift from Yue Zhang. The 2kb *Pges-1* fragment upstream of *ges-1* ATG was generated by PCR amplification from wild-type (N2) genomic DNA using the following primers (pSH9\_ *Pges-1\_*F: 5'-ATGCCTGCAGGTCGACTCTAGAGGATCCCCAAACTCCGAACTATGATGACGAAAAAATGT-3' and pSH9\_*Pges-1\_*R: 5'-AGGATGATGGTTCATATCATGTGTGGACATCTGAATTCAAAGATAAGATATGTAATAGAT-3'). The *set-2.a* cDNA fragment was generated by PCR amplification from pAS2.1 (a gift from Dr. Francesca Palladino) using the following primers (pSH9\_*set-2.a\_*F: 5'-ATCTATTACATATCTTATCTTTGAATTCAGATGTCCACACATGATATGAACCATCATCCT- 3' and pSH9\_*set-2.a\_*R: 5'-AACTAGGTGAAAGTAGGATGAGACAGCCCCTCAATTAAGATATCCACGACACGTCTTCGC- 3'), and was corrected for a short missing sequence. The pIM26 fragment was amplified by PCR using the following primers (pSH9_pIM26_F: 5'-GCGAAGACGTGTCGTGGATATCTTAATTGAGGGGCTGTCTCATCCTACTTTCACCTAGTT -3'and pSH9_pIM26_R: 5'-ACATTTTTTCGTCATCATAGTTCGGAGTTTGGGGATCCTCTAGAGTCGACCTGCAGGCAT-3'). Three fragments were assembled via Gibson assembly^[@R39]^.

All fragments generated via PCR amplification were sequence-verified in the final plasmid to ensure no mutations were introduced.

Generation of transgenic worm strains {#S20}
-------------------------------------

The strain carrying extra-chromosomal arrays of \[*Pges-1::fat-7; myo-3::mCherry*\] was generated by injecting wild-type N2 (ABR) worms with pSH1 and a co-injection plasmid pCFJ104, with a muscle specific *myo-3* promoter driving the mCherry gene (*Pmyo-3::*mCherry, made by Dr. Erik Jorgensen, Addgene plasmid \#19328). The strain carrying extra-chromosomal arrays of \[*Pges-1::set-2a cDNA; myo-3::mCherry*\] was generated by injecting *set-2(ok952)* (ABR10) worms with pSH9 and *Pmyo-3::*mCherry. The injection mixture of both plasmids was at a final concentration of 50 ng/μL. Control strains were generated by injecting wild-type N2 (ABR) worms with the co-injection marker (*Pmyo-3::mCherry*) at final a concentration of 50 ng/μL.

Worms containing extra-chromosomal arrays were selected based on mCherry fluorescence in the body wall muscles. In transgenic worms also carrying a GFP reporter, GFP fluorescence was used as a primary marker for strain maintenance. Overexpression of *fat-7* in wild-type transgenic worms was confirmed by RT-qPCR with primers designed to detect *fat-7* mRNA. Overexpression of *set-2.a* in *set-2(ok952)* mutant transgenic worms was confirmed by RT-qPCR with primers designed to detect transgenic (wild-type) but not mutant *set-2.a* mRNA. Functional validation of *set-2* intestine rescue transgenic lines was conducted via RT-qPCR analysis of intestinal targets of COMPASS H3K4me3 complex, *dod-23* and *asm-2*, which are normally downregulated in *set-2(ok952)* mutants. Primer sequences are listed in [Supplementary Table 7](#SD8){ref-type="supplementary-material"}.

GC-MS quantification of fatty acids {#S21}
-----------------------------------

Quantification of total triglycerides and total phospholipids levels and profiling of long-chain fatty acids were performed as described^[@R33]^ with the following modifications. For each condition, 500-1000 age-synchronized animals were used. For GC-MS, an Agilent 7890A gas chromatograph equipped with an HP-5MS column (30 m × 0.25 μm I.D. × 0.25 μm, Agilent) using helium as a carrier gas was used, and 1 μm of each sample was injected at a 10:1 split ratio. The initial oven temperature was set to 150°C, increased to 220°C at 20°C/min, increased to 230°C at 2°C/min, increased to 320°C at 50°C/min, and held for 2 minutes at this temperature. Fatty acid abundance was expressed as a ratio (μg/mg) of fatty acid concentration (μg/mL) to protein concentration (mg/mL) for each sample. In all GC-MS figure panels involving comparisons to the empty vector control (unless otherwise mentioned), raw fatty acid concentration (μg/mg) of each condition was normalized to raw fatty acid concentration (μg/mg) of the empty vector control. The final ratio is expressed as relative fatty acid levels. Raw GC-MS data for all figure panels are provided in [Supplementary Table 8](#SD9){ref-type="supplementary-material"}.

Fertility assessment {#S22}
--------------------

Fertility of N2 worms treated with *ash-2* RNAi or empty vector control was assayed at 20°C. After a one-hour egglay, and eggs were maintained at 20°C until worms reached initiation of reproduction (2.5 day of life). Each of 30 reproductive worms from each condition was transferred onto individual 3.5 cm plate seeded with corresponding bacteria. Individual worms were transferred onto a new plate every day, and the number of fertilized eggs (eggs with visible shell) and unfertilized oocytes (eggs without visible shell) were assessed on the old plate. The old plate with eggs was incubated at 20°C for an additional day, and the number of hatched progeny (live brood size) was counted. Fertility was assessed daily until no more hatched worms, fertilized eggs, or unfertilized oocytes were seen on each plate. This experiment was conducted in a blinded manner.

Fatty acid supplementation {#S23}
--------------------------

The fatty acid supplementation protocol was adapted from^[@R40]^ with the following modifications. To facilitate fatty acid dissolution, the detergent Tergitol (type NP-40, Sigma-Aldrich) was added to a final concentration of 0.001% in liquid NGM agar media for both non-supplemented and supplemented plates prior to autoclaving. NGM plates for RNAi experiments were prepared as described^[@R6]^, and HT115 bacteria were used for all supplementation experiments. A final concentration ranging from 0.1 mM to 4 mM of oleic acid was used during the initial experimental optimization, and a final concentration of 0.8 mM was used for all fatty acids in subsequent supplementation experiments. HT115 bacteria expressing empty vector or the appropriate RNAi were seeded onto plates containing the respective fatty acids at room temperature for 24-48 hours before the addition of worms to ensure incorporation of fatty acids into feeding bacteria. Successful incorporation of supplemented fatty acids into the HT115 bacteria and into the worms was confirmed by GC-MS.

Data availability statement {#S24}
---------------------------

RNA-seq data are available at Sequence Read Archive (SRA) under accession number PRJNA343151. The code for RNA-seq analysis is available on the Brunet Lab Github: [https://github.com/brunetlab](http://https://github.com/brunetlab).

Extended Data {#S25}
=============

![Deficiency in H3K4me3 modifiers leads to fat accumulation in the intestine without impacting fertility\
**a**, ORO quantification. Mean ± s.d., n ≥ 17 worms per condition. **b**, ORO images. Scale bar: 100 μm. **c**, ORO quantification. Mean ± s.d., n ≥ 9 dissected intestines per condition. **d-e**, Nile Red staining and quantification. Mean ± s.d., n ≥ 7 dissected intestines (**d**) or n ≥ 11 worms (**e**) per condition. Scale bar: 100 μm. **f**, Autofluorescence and quantification. Mean ± s.d., n ≥ 17 worms per condition. Scale bar: 100 μm. **g**, Fertility quantification of live brood size (**i**), fertilized eggs (**ii**), and unfertilized oocytes (**iii**) laid per worm. Mean ± s.d., n ≥ 25 worms per condition. **h**, RT-qPCR. Mean ± s.e.m. of 2 independent experiments, each with 2-3 biological replicates. **i**, RT-qPCR. Mean ± s.e.m. from 2 independent experiments, each with 2-3 biological replicates. **j**, ORO quantification. Mean ± s.d., n ≥ 26 worms per condition. **k**, ORO quantification. Mean ± s.d., n ≥ 29 worms per condition. **l**, RT-qPCR. Mean ± s.e.m. of 3 biological replicates. **m**, D.I.C. (Nomarski) and GFP fluorescence images. **n**, ORO quantification. Mean ± s.d., n ≥ 26 worms per condition. **a-f, k** (rescue line \#1), **n**, Representative of 2 experiments. *P* values: **a, c-g**, Two-tailed Mann-Whitney; **h-i**, Two-tailed Mann-Whitney with Benjamini-Hochberg correction; **j-k, n**, Kruskal-Wallis with Dunn\'s correction; **l**, Two-tailed *t*-test with Benjamini-Hochberg correction. \* *P* \< 0.05, \*\* *P* \< 0.01.](nihms-849349-f0006){#F6}

![The delta-9 desaturases FAT-5 and FAT-7 support MUFA accumulation in H3K4me3-methyltransferase deficient worms\
**a**, GC-MS quantification of MUFAs. Mean ± s.e.m. of 2 independent experiments, each with 3 biological replicates. **b-c**, RT-qPCR. Mean ± s.e.m. of 2 independent experiments, each with 3 biological replicates. **d**, GC-MS quantification of MUFAs. Mean ± s.e.m. of 2 independent experiments, each with 2-3 biological replicates. **e**, RT-qPCR. Mean ± s.e.m. of 2 independent experiments, each with 3 biological replicates. *P* values: **a-e**, Two-tailed Mann-Whitney with Benjamini-Hochberg correction. \* *P* \< 0.05, \*\* *P* \< 0.01.](nihms-849349-f0007){#F7}

![RNA-seq on micro-dissected germlines and intestines and functional validation of ASH-2 targets\
**a**, RNA-seq tissue sample collection pipeline. **b**, Principal component analysis (PCA) with both intestine and germline samples (left), only intestine samples (middle), or only germline samples (right). **c**, RT-qPCR. Mean ± s.e.m. of 2 independent experiments, each with 2-3 biological replicates. **d-g**, ORO quantification. Mean ± s.d., n ≥ 15 worms per condition. **h**, RT-qPCR. Mean ± s.e.m. of 2 independent experiments, each with 3 biological replicates. **i-j**, ORO quantification. Mean ± s.d., n ≥ 21 (**i**) and n ≥ 27 (**j**) worms per condition. **k**, RT-qPCR. Mean ± s.e.m. of 2 independent experiments, each with 3 biological replicates. **l**, GC-MS. Mean ± s.e.m. of 2 independent experiments, each with 3 biological replicates. **m**, ORO quantification. Mean ± s.d., n ≥ 19 worms per condition. **n**, RT-qPCR. Mean ± s.e.m. of 2 independent experiments, each with 3 biological replicates. **o**, Lifespan extension by *ash-2* RNAi is reduced in *rsks-1(ok1255)* mutants (13.12%) compared to wild-type worms (29.20%) (*P* \< 0.0001, two-way ANOVA). **p**, *let-363/mTOR* RNAi and *daf-15/Raptor* RNAi extend lifespan in wild-type worms (*P* \< 0.0001, log-rank), but not in *set-2(ok952)* mutants. **d** (except *rrf-1* data), **i-j**, Representative of 2 experiments. *P* values: **c, k, l, n**, Two-tailed Mann-Whitney with Benjamini-Hochberg correction; **h**, Two-tailed Mann-Whitney; **d-g, i-j, m**, Kruskal-Wallis with Dunn\'s correction. \* *P* \< 0.05, \*\* *P* \< 0.01.](nihms-849349-f0008){#F8}

![Role of SBP-1/SREBP, MDT-15/MED15, NHR-49, and NHR-80 in the fat accumulation and longevity of H3K4me3-methyltransferase deficient worms\
**a-d**, Images and quantification of SBP-1 nuclear accumulation. Mean ± s.d. of 2 independent experiments, each with 4-6 nuclei per worm of ≥ 8 worms per condition. **e**, RT-qPCR. Mean ± s.e.m. of 2 independent experiments, each with 3 biological replicates. **f**, GC-MS quantification of MUFAs. Mean ± s.e.m. of 2 independent experiments, each with 2-3 biological replicates. **g**, ORO quantification. Mean ± s.d., n ≥ 21 worms per condition. **h**, *ash-2* RNAi extends lifespan in wild-type worms (*P* \< 0.0001, log-rank), but not in *mdt-15* RNAi worms. **i**, ORO quantification, Mean ± s.d., n ≥ 24 worms per condition. **j**, *ash-2* RNAi extends lifespan in both wild-type worms and *nhr-49(nr2041)* mutants (*P* \< 0.0001, log-rank). **k**, ORO quantification. Mean ± s.d., n ≥ 27 worms per condition. **l**, *ash-2* RNAi extends lifespan in both wild-type worms and *nhr-80(tm1011)* mutants (*P* \< 0.0001, log-rank). **i-k**, Representative of 2 experiments. *P* values: **a**, Two-tailed Mann-Whitney; **b-d, g, i, k**, Kruskal-Wallis with Dunn\'s correction; **e-f**, Two-tailed Mann-Whitney with Benjamini-Hochberg correction. \* *P* \< 0.05.](nihms-849349-f0009){#F9}

![Delta-9 desaturases FAT-6 and FAT-7 and MUFA oleic acid mediate the longevity of H3K4me3-methyltransferase deficient worms\
**a**, ORO quantification. Mean ± s.d., n ≥ 29 worms per condition. **b**, *ash-2* RNAi leads to lifespan extension in control (*P* \< 0.0001, log-rank), but not in *fat-6(tm331);fat-7(wa36)* mutants. **c**, *ash-2* RNAi extends lifespan in both wild-type worms and *fat-7(wa36)* single mutants (*P* \< 0.0001, log-rank). **d**, *ash-2* RNAi extends lifespan in *fat-6(tm331)* single mutants (*P* = 0.0162, log-rank), but lifespan extension by *ash-2* RNAi is reduced in *fat-6(tm331)* mutants (9.26%) compared to wild-type worms (20.46%) (*P* = 0.0072, two-way ANOVA). **e**, *ash-2* RNAi extends lifespan in *fat-5(tm420);fat-7(wa36)* double mutants (*P* \< 0.0001, log-rank). **f**, *ash-2* RNAi extends lifespan in *fat-5(tm420);fat-6(tm331)* worms (*P* = 0.0002, log-rank), but lifespan extension by *ash-2* RNAi is reduced in *fat-5(tm420);fat-6(tm331)* mutants (14.03%) compared to wild-type worms (20.46%) (*P* = 0.0358, two-way ANOVA). **g-h**, GC-MS quantification of oleic acid. Mean ± s.e.m. of 3 biological replicates. **i**, ORO quantification. Mean ± s.d., n ≥ 13 worms per condition. Boxed conditions are identical to [Fig. 4g](#F4){ref-type="fig"}. **j**, Oleic acid supplementation extends lifespan (*P* \< 0.0001, log-rank), which is not further extended by *ash-2* RNAi. Oleic acid supplementation extends lifespan in *fat-7;ash-2* RNAi worms (*P* \< 0.0001, log-rank). Boxed conditions are identical to [Fig. 4h](#F4){ref-type="fig"}. **k**, ORO quantification. Mean ± s.d., n ≥ 21 worms per condition. **l**, GC-MS quantification of MUFAs. Mean ± s.e.m. of 2 independent experiments, each with 2-3 biological replicates. **m**, RT-qPCR. Mean ± s.e.m. of 2 independent experiments, each with 3 biological replicates. **n**, ORO quantification. Mean ± s.d., n ≥ 25 worms per condition. **o**, *ash-2* RNAi extends lifespan in control (*P* \< 0.0001, log-rank) but not *fat-2* RNAi worms. **c, i-j, n-o**, Representative of 2 experiments. *P* values: **a, g-i, k, n**, Kruskal-Wallis with Dunn\'s correction; **l-m**, Two-tailed Mann-Whitney with Benjamini-Hochberg correction. \* *P* \< 0.05, \*\* *P* \< 0.01.](nihms-849349-f0010){#F10}

![Dietary supplementation of MUFAs, but not PUFAs, extends lifespan in wild-type worms\
**a**, GC-MS. Mean ± s.e.m. of 2 independent experiments, each with 2-3 biological replicates. **b**, Cis-vaccenic acid supplementation extends lifespan in wild-type worms (*P* \< 0.0001, log-rank). Inset: ORO quantification. Mean ± s.d., n ≥ 20 worms per condition. **c**, GC-MS. Mean ± s.e.m. of 2 independent experiments, each with 3 biological replicates. **d**, Linoleic acid supplementation does not extend lifespan in wild-type worms. Inset: ORO quantification. Mean ± s.d., n ≥ 23 worms per condition. **e**, GC-MS. Mean ± s.e.m. of 2 independent experiments, each with 3 biological replicates. **f**, Alpha-linolenic acid supplementation does not increase the lifespan of wild-type worms. Inset: ORO quantification. Mean ± s.d., n ≥ 23 worms per condition. **g**, RT-qPCR. Mean ± s.e.m. of 3 biological replicates. **h**, ORO quantification. Mean ± s.d., n ≥ 54 worms per condition. **i**, Overexpression of FAT-7 extends lifespan (*P* \< 0.0001, log-rank), which is not further extended by dietary oleic acid. Boxed regions are identical to [Fig. 5g](#F5){ref-type="fig"}. **j**, Proposed model by which *ash-2* deficiency in the germline could lead to the fat metabolic switch in the intestine. **b, d, f**, Representative of 2 experiments. *P* values: **a, c, e**, Two-tailed Mann-Whitney with Benjamini-Hochberg correction; **b** inset**, d** inset, **f** inset, Two-tailed Mann-Whitney; **g**, Kruskal-Wallis test with Dunn\'s correction (non-significant, likely due to small sample size). One-way ANOVA with Bonferroni\'s correction. **h**, Kruskal-Wallis with Dunn\'s correction; \* *P* \< 0.05, \*\* *P* \< 0.01, \*\*\* *P* \< 0.001.](nihms-849349-f0011){#F11}

###### List of ASH-2 candidate targets

List of candidate targets of ASH-2 based on our gene expression dataset as well as published datasets.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Candidates   Datasets                                                               Functions                                                                                            Expression
  ------------ ---------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------- ---------------------------------
  *tbh-1*      RNA-seq of *ash-2* knockdown worms (adult, micro-dissected tissues)    Tyramine beta-hydroxylase, Required for biosynthesis of the octopamine neurotransmitter, Longevity   Germline

  *nhr-10*     RNA-seq of *ash-2* knockdown worms (adult, micro-dissected tissues)    Nuclear hormone receptor, Fat metabolism                                                             Intestine, Germline

  *unc-132*    RNA-seq of *ash-2* knockdown worms (adult, micro-dissected tissues)    Unknown roles in fat metabolism and longevity                                                        Germline

  *F21A3.11*   RNA-seq of *ash-2* knockdown worms (adult, micro-dissected tissues)    Predicted to have acid phosphatase activity and metal ion binding activity, Longevity                Intestine

  *asm-2*      RNA-seq of *ash-2* knockdown worms (adult, micro-dissected tissues)\   Acid sphingomyelinase                                                                                Intestine
               Microarray of *ash-2* knockdown worms (larval, whole worms)                                                                                                                 

  *dod-23*     RNA-seq of *ash-2* knockdown worms (adult, micro-dissected tissues)\   Determinant of adult lifespan                                                                        Intestine
               Microarray of *ash-2* knockdown worms (larval, whole worms)                                                                                                                 

  *acs-2*      Microarray of *ash-2* knockdown worms (larval, whole worms)            Fatty acid beta-oxidation                                                                            Intestine (predicted)

  *acdh-2*     Microarray of *ash-2* knockdown worms (larval, whole worms)            Fatty acid beta-oxidation                                                                            Intestine (predicted)

  *rsks-1*     ASH-2 ChIP-chip (whole embryos)                                        S6 kinase (S6K), Fat metabolism, Longevity                                                           Germline (predicted)

  *aak-2*      ASH-2 ChIP-chip (whole embryos)                                        AMPK subunit, Nutrient sensing, Longevity                                                            Intestine, Germline (predicted)
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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![H3K4me3-methyltransferase deficiency in the germline leads to fat accumulation in the intestine\
**a**, ORO staining images and quantification. Mean ± s.d., n ≥ 55 worms per condition. **b**, As in **a**, n ≥ 16 worms per condition. **c**, As in **a**, n ≥ 29 worms (upper panels) or n ≥ 25 intestinal cells (lower panels) per condition. **d**, Gas chromatography-mass spectrometry (GC-MS) quantification. Mean ± s.e.m of 2 independent experiments, each with 3 biological replicates. **e**, As in **a**, n ≥ 26 worms per condition. **f**, *ash-2* RNAi extends lifespan in wild-type (*P* \< 0.0001, log-rank) but not in *rde-1(ne219)*; *Is\[Pnhx-2::rde-1\]* worms. **g**, As in **a**, n ≥ 18 worms per condition. **h**, *ash-2* RNAi extends lifespan in both wild-type and *rde-1(ne219)*; *Si\[Pmex-5::rde-1\]* worms (*P* \< 0.0001, log-rank). **b, c, e-h**, Representative of 2 experiments. *P* values: **a, b, e, g**, Kruskal-Wallis with Dunn\'s correction; **c, d**, Two-tailed Mann-Whitney.](nihms-849349-f0001){#F1}

![H3K4me3-methyltransferase deficiency results in elevated MUFAs and upregulation of delta-9 desaturases\
**a**, Fat metabolism pathways with genes used in RT-qPCR. **b-c**, GC-MS quantification of fatty acids. Mean ± s.e.m. of 2-3 independent experiments, each with 3 biological replicates. **d**, RT-qPCR. Mean ± s.e.m. of 2 independent experiments, each with 3 biological replicates. Solid red bars: delta-9 desaturases. **e**, RT-qPCR. Mean ± s.e.m. of 2 independent experiments, each with 2-3 biological replicates. **f**, Images and quantification of GFP fluorescence. Mean ± s.d., n ≥ 18 worms per condition. Representative of 2 (FAT-5) and 3 (FAT-7) experiments. Scale bar: 100 μm. **g-h**, GC-MS quantification of MUFAs. Mean ± s.e.m. of 3 (**g**) and 2 (**h**) independent experiments, each with 2-3 biological replicates. *P* values: Two-tailed Mann-Whitney (with Benjamini-Hochberg correction for \> 2 conditions). \* *P* \< 0.05, \*\* *P* \< 0.01, \*\*\* *P* \< 0.001.](nihms-849349-f0002){#F2}

![H3K4me3-methyltransferase germline targets impact fat metabolism\
**a**, RT-qPCR. Mean ± s.e.m. of 2 independent experiments, each with 3 biological replicates. **b**, ORO quantification. Mean ± s.d., n ≥ 23 worms per condition. Representative of 2 experiments. **c**, GC-MS profiles of fatty acids. Mean ± s.e.m. of 2 independent experiments, each with 2-3 biological replicates. **d**, RT-qPCR. Mean ± s.e.m. of 2 independent experiments, each with 3 biological replicates. *P* values: **b**, Kruskal-Wallis with Dunn\'s correction; **a, c, d**, Two-tailed Mann-Whitney with Benjamini-Hochberg correction. \* *P* \< 0.05, \*\* *P* \< 0.01.](nihms-849349-f0003){#F3}

![MUFA accumulation is critical for the longevity of H3K4me3-methyltransferase deficient worms\
**a**, Conserved transcriptional network regulating delta-9 desaturase genes. **b**, Images and quantification of SBP-1 nuclear accumulation. Mean ± s.d. of 2 independent experiments, each with n = 4-6 nuclei per worm of ≥ 8 worms per condition. **c**, RT-qPCR. Mean ± s.e.m. of 3 independent experiments, each with 3 biological replicates. **d**, GC-MS. Mean ± s.e.m. of 2 independent experiments, each with 2-3 biological replicates. **e**, ORO quantification. Mean ± s.d., n ≥ 32 worms per condition. **f**, Lifespan extension by *ash-2* RNAi is reduced in *sbp-1* RNAi (9.78%) compared to control worms (21.90%) (*P* = 0.0003, two-way ANOVA). **g**, As in **e**, n ≥ 13 worms per condition. **h**, Dietary oleic acid extends lifespan in the context of *fat-7*;*ash-2* double RNAi (*P* \< 0.0001, log-rank). **g, h**, Representative of 2 experiments. *P* values: **b**, Two-tailed Mann-Whitney; **e, g**, Kruskal-Wallis with Dunn\'s correction; **c, d**, Two-tailed Mann-Whitney with Benjamini-Hochberg correction. \* *P* \< 0.05, \*\* *P* \< 0.01.](nihms-849349-f0004){#F4}

![Dietary supplementation of MUFAs is sufficient to extend lifespan\
**a**, Chemical structure of fatty acids used in supplementation experiments. **b**, GC-MS. Mean ± s.e.m. of 3 independent experiments, each with 2-3 biological replicates. **c**, Oleic acid supplementation extends lifespan in wild-type worms (*P* \< 0.0001, log-rank). Inset: ORO quantification. Mean ± s.d., n ≥ 27 worms per condition. **d**, GC-MS. Mean ± s.e.m. of 2 independent experiments, each with 2-3 biological replicates. **e**, Palmitoleic acid supplementation extends lifespan in wild-type worms (*P* \< 0.0001, log-rank). Inset: as in **c**, n ≥ 45 worms per condition. **f**, Mean lifespan changes in independent supplementation experiments (*P* values: log-rank). **g**, FAT-7 overexpression extends lifespan (*P* \< 0.0001, log-rank), which is not further extended by dietary oleic acid. *P* values: Two-tailed Mann-Whitney (Benjamini-Hochberg correction for \> 1 comparison). \* *P* \< 0.05, \*\* *P* \< 0.01, \*\*\* *P* \< 0.001.](nihms-849349-f0005){#F5}
